Effect of the Novel Prostaglandin A_1 Derivative TEI-6363 on ROS17/2.8 Cell Differentiation In Vitro
スポンサーリンク
概要
- 論文の詳細を見る
The effect of TEI−6363(5−[E−4−N, N−dimethylaminophenylmethylene]−4−hydroxy−2−[1−methyl imidazole−2−ilthio]−4−[4−phenylbutyl]−2−cyclopentenone), a chemically synthesized prostaglandin A1 derivative, on cell proliferation and osteoblastic differentiation was investigated concurrently.ROS17/2.8 cells(a rat osteosarcoma−derived cell line)were treated with TEI−6363 at two concentrations, 10-7 and 10-6M, and viable cells were counted to assess cytotoxic effects and determine the growth curve.After 96 h of treatment, there was no evidence of any effect of TEI−6363 on cell viability at either concentration.However, a clear inhibitory effect on cell proliferation was observed after treatment with 10-6M TEI−6363 for 24 h or longer.A pulsetreatment experiment showed that TEI−6363 induced the inhibition of proliferating ROS17/2.8 cells 24 h after addition.The inhibition of proliferation was associated with G1−arrest demonstrated by flow cytometric analysis, and incorporation of [3H]thymidine by ROS17/2.8 cells was decreased.Osteoblastic differentiation(assessed on the basis of increased alkaline phosphatase activity and collagen synthesis)was induced by TEI−6363 treatment at 10-6M following G1−arrest and inhibition of cell proliferation.These results suggest that TEI−6363 arrested the cell cycle of ROS17/2.8 cells at the G1 phase and induced osteoblastic differentiation.These results did not appear to be dependent on a marked cytotoxic effect.
- 社団法人 日本薬理学会の論文
- 2000-07-01
著者
-
Uno Hiroshi
Teijin Pharmaceuticals Development Research Laboratreis Safety Research Department
-
AZUMA Yoshiaki
Teijin Pharmaceutical Co
-
Miura Daishiro
Teijin Pharmaceuticals development research laboratreis, Safety research department
-
Kiyoki Mamoru
Teijin Institute For Bio-medical Research
-
Miura Daishiro
Teijin Institute For Bio-medical Research
-
Azuma Yoshiaki
Teijin Institute For Bio-medical Research
-
Izawa Yoshihiro
Teijin Institute For Bio-medical Research
-
OHTA Tomohiro
Teijin Institute for Biomedical Research
-
Ohta Tomohiro
Teijin Institute For Bio-medical Research
-
Uno Hiroshi
Teijin Institute For Bio-medical Research
関連論文
- Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period
- Examination of immunosuppression by rat peripheral lymphocytes phenotyping : basic examination using rat peripheral blood after dosing DMBA, benzene, EGME (IMMUNE AND ALLERGIC SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annua
- P12-04 Basic examination a reticulocytes count using a flow-cytometer (EPICS XL-MCL) : A study of quality control method using Retic-Chex as a control material.
- P-78 Basic Study on the Using Flow-cytometer (EPICSXL) for the Bone Marrow Examination.(Proceedings of the 27th Annual Meeting)
- 21B-10-3 Hematological and blood chemical study of the inhibitory effect on the hematopoietic system in the chemotherapeutics administered to rabbit.
- 21B-09-3 Basic Examination of Reticulocytes Count Using the Flow-cytometer (EPICS XL) : A Comparative Study Between Flow-cytometer Method and Conventional Method Using Hemolytic-anemia Animals.
- Increased urinary excretion of pyridinium cross-links as markers of bone resorption in bone metastases of lung cancer
- Effect of the Novel Prostaglandin A_1 Derivative TEI-6363 on ROS17/2.8 Cell Differentiation In Vitro
- METABOLIC FATE OF FEPRAZONE
- Fullerene (C_) Is Negative in the In Vivo Pig-A Gene Mutation Assay
- Effect of 1α-Hydroxyvitamin D3 in Rats with Experimental Renal Osteodystrophy
- Reversibility of alendronate-induced contraction in human osteoclast-like cells formed from bone marrow cells in culture
- Effective use of the Pig-a gene mutation assay for mutagenicity screening : measuring CD59-deficient red blood cells in rats treated with genotoxic chemicals
- Alendronate Modulates Osteogenesis of Human Osteoblastic Cells In Vitro.